Breast Cancer Research and Treatment

, Volume 116, Issue 1, pp 129–130

Cognitive impairments associated with breast cancer treatments: results from a longitudinal study

Erratum

DOI: 10.1007/s10549-008-0208-x

Cite this article as:
Quesnel, C., Savard, J. & Ivers, H. Breast Cancer Res Treat (2009) 116: 129. doi:10.1007/s10549-008-0208-x

Erratum to: Breast Cancer Res Treat DOI 10.1007/s10549-008-0114-2

Unfortunately, mistakes were introduced by Springer in Table 3 of this article. Please find below the corrected table.
Table 3

Adjusted means and effect sizes on the ANCOVA comparing breast cancer patients at baseline and healthy controls on variables of cognitive functioning

Test

C

R

C

CC

t (116)

dc

R

RC

t (116)

dc

CFT

    Copy

33.17

33.41

−0.26

−0.07

32.96

32.42

0.54

0.16

    Immediate recall

18.13

15.59

1.61

0.45

15.89

17.89

−1.16

−0.36

    Delayed recall

17.46

14.75

1.74

0.49

15.94

17.38

−0.85

−0.26

RAVLT

    Total recall

10.94

10.56

0.89

0.25

10.63

10.96

−0.72

−0.22

    Delayed recall

11.53

10.93

0.89

0.25

10.68

11.42

−0.99

−0.30

    Recognition

14.49

14.44

0.21

0.06

14.53

14.60

−0.27

−0.08

TMTa

    A

27.20

31.96

−1.78*

0.50

28.70

26.51

0.75

−0.23

    B

67.46

72.45

−0.73

0.21

71.22

62.88

1.12

−0.34

SDMT

    Written

50.84

52.72

−0.84

−0.24

49.96

54.39

−1.81*

−0.56

    Oral

58.46

58.54

−0.03

−0.01

57.66

65.99

−2.77***

−0.85

DS

    Forward

7.48

8.50

−1.98**

−0.55

7.80

8.53

−1.29

−0.39

    Backward

6.21

6.54

−0.50

−0.14

6.54

6.87

−0.47

−0.14

VMS

    Forward

7.01

7.37

−0.76

−0.21

7.94

8.04

−0.19

−0.06

    Backward

7.14

7.52

−0.93

−0.26

7.81

7.15

1.44

0.45

VFT

40.59

34.34

2.34**

0.65

38.04

35.12

1.00

0.31

Ruff 2 & 7

    Automatic

155.79

151.83

0.41

0.12

139.08

158.38

−1.75*

−0.59

    Controlled

128.39

118.42

1.43

0.42

112.05

126.99

−1.90*

−0.64

    CFQb

36.13

42.71

−2.20**

0.64

34.51

35.06

−0.17

0.05

    QLQ-Cb

58.75

79.43

−1.54

0.45

59.99

44.44

1.06

−0.33

Notes: C = Chemotherapy group; CC = Control group matched to the C group; R = Radiotherapy group; RC = Control group matched to the R group; CFT = Complex Figure Test; RAVLT = Rey Auditory Verbal Learning Test; TMT = Trail Making Test; SDMT = Symbol Digit Modalities Test; DS = Digit Span; VMS = Visual Memory Span; VFT = Verbal Fluency Test; CFQ = Cognitive Failures Questionnaire; QLQ-C = Cognitive subscale of the EORTC Quality of Life Questionnaire

aA higher score on the TMT A and B indicates a poorer performance at this test

bA higher score on the CFQ and QLQ-C indicates a poorer self-reported cognitive functioning

cA positive score indicates a better cognitive functioning in breast cancer patients as compared to their healthy controls

* P < 0.10, ** P < 0.05, *** P < 0.01

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  1. 1.School of PsychologyUniversité Laval and Laval University Cancer Research CenterQuebecCanada

Personalised recommendations